Fig. 5From: Genetically modified "obligate" anaerobic Salmonella typhimurium as a therapeutic strategy for neuroblastomaSal-YB1 could decrease the survival of neuroblastoma via JC-1 assay. JC-1 flow cytometry indicated that the survival of neuroblastoma (gated in the upper box) decreased after either Sal-YB1 direct treatment or co-culture with Sal-YB1 pre-treated activated macrophages culture supernatantBack to article page